Announcements and Notices - [Other - Miscellaneous]

3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.

Voluntary Announcement - Increase In Shareholding By Chief Financial Officer

Announcements and Notices - [Other - Business Update]

Voluntary Announcement - Mandi Ranked The First Place On Multiple Platforms In "Double 11" Of 2024

Voluntary Announcement
Shenyang Sunshine Has Entered Into A Cooperation Agreement
With Haihe Biopharma In Respect Of Paclitaxel Oral Solution

Financial Statements/ESG Information - [Interim/Half-Year Report]

2024 Interim Report

Announcements and Notices - [Share Scheme / Connected Transaction]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3SBio Inc (1530 HK)

Voluntary Announcement - Increase In Shareholding By Chief Financial Officer

Voluntary Announcement - Mandi Ranked The First Place On Multiple Platforms In "Double 11" Of 2024

Voluntary Announcement Shenyang Sunshine Has Entered Into A Cooperation Agreement With Haihe Biopharma In Respect Of Paclitaxel Oral Solution

2024 Interim Report

Supplemental Announcement In Relation To The Connected Transaction On Grant Of Share Awards To Connected Persons Pursuant To The Share Award Scheme

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)